191 related articles for article (PubMed ID: 12893078)
1. Folic acid mediated attenuation of loss of heterozygosity of DCC tumor suppressor gene in the colonic mucosa of patients with colorectal adenomas.
Nagothu KK; Jaszewski R; Moragoda L; Rishi AK; Finkenauer R; Tobi M; Naumoff JA; Dhar R; Ehrinpreis M; Kucuk O; Majumdar AP
Cancer Detect Prev; 2003; 27(4):297-304. PubMed ID: 12893078
[TBL] [Abstract][Full Text] [Related]
2. Chemopreventive role of folic acid in colorectal cancer.
Majumdar AP; Kodali U; Jaszewski R
Front Biosci; 2004 Sep; 9():2725-32. PubMed ID: 15353309
[TBL] [Abstract][Full Text] [Related]
3. Copy number of the Adenomatous Polyposis Coli gene is not always neutral in sporadic colorectal cancers with loss of heterozygosity for the gene.
Zauber P; Marotta S; Sabbath-Solitare M
BMC Cancer; 2016 Mar; 16():213. PubMed ID: 26970738
[TBL] [Abstract][Full Text] [Related]
4. Involvement of the multiple tumor suppressor genes and 12-lipoxygenase in human prostate cancer. Therapeutic implications.
Gao X; Porter AT; Honn KV
Adv Exp Med Biol; 1997; 407():41-53. PubMed ID: 9321930
[TBL] [Abstract][Full Text] [Related]
5. Detection of the DCC gene product in normal and malignant colorectal tissues and its relation to a codon 201 mutation.
Schmitt CA; Thaler KR; Wittig BM; Kaulen H; Meyer zum Büschenfelde KH; Dippold WG
Br J Cancer; 1998 Feb; 77(4):588-94. PubMed ID: 9484816
[TBL] [Abstract][Full Text] [Related]
6. Loss of heterozygosity of APC and DCC tumor suppressor genes in human sporadic colon cancer.
Sturlan S; Kapitanović S; Kovacević D; Lukac J; Spaventi S; Spaventi R; Pavelić K
J Mol Med (Berl); 1999 Mar; 77(3):316-21. PubMed ID: 10090594
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of the deleted in colorectal cancer gene protein expression in high-risk resected gastric carcinoma.
Bamias AT; Bai MC; Agnantis NJ; Michael MC; Alamanos YP; Stefanaki SV; Razi ED; Skarlos DV; Kappas AM; Pavlidis NA
Cancer Invest; 2003 Jun; 21(3):333-40. PubMed ID: 12901278
[TBL] [Abstract][Full Text] [Related]
8. Loss of expression of the DCC gene during progression of colorectal carcinomas in familial adenomatous polyposis and non-familial adenomatous polyposis patients.
Kikuchi-Yanoshita R; Konishi M; Fukunari H; Tanaka K; Miyaki M
Cancer Res; 1992 Jul; 52(13):3801-3. PubMed ID: 1319833
[TBL] [Abstract][Full Text] [Related]
9. Age-associated loss of heterozygosity of tumor suppressor genes in the gastric mucosa of humans.
Moragoda L; Jaszewski R; Kulkarni P; Majumdar AP
Am J Physiol Gastrointest Liver Physiol; 2002 Jun; 282(6):G932-6. PubMed ID: 12016117
[TBL] [Abstract][Full Text] [Related]
10. Chemopreventive effects of dietary folate on intestinal polyps in Apc+/-Msh2-/- mice.
Song J; Sohn KJ; Medline A; Ash C; Gallinger S; Kim YI
Cancer Res; 2000 Jun; 60(12):3191-9. PubMed ID: 10866310
[TBL] [Abstract][Full Text] [Related]
11. Reduced expression of APC and DCC gene protein in breast cancer.
Ho KY; Kalle WH; Lo TH; Lam WY; Tang CM
Histopathology; 1999 Sep; 35(3):249-56. PubMed ID: 10469217
[TBL] [Abstract][Full Text] [Related]
12. Somatic allelic loss at the DCC, APC, nm23-H1 and p53 tumor suppressor gene loci in human prostatic carcinoma.
Brewster SF; Browne S; Brown KW
J Urol; 1994 Apr; 151(4):1073-7. PubMed ID: 7510345
[TBL] [Abstract][Full Text] [Related]
13. The DCC gene product in cellular differentiation and colorectal tumorigenesis.
Hedrick L; Cho KR; Fearon ER; Wu TC; Kinzler KW; Vogelstein B
Genes Dev; 1994 May; 8(10):1174-83. PubMed ID: 7926722
[TBL] [Abstract][Full Text] [Related]
14. Concordance of genetic alterations in poorly differentiated colorectal neuroendocrine carcinomas and associated adenocarcinomas.
Vortmeyer AO; Lubensky IA; Merino MJ; Wang CY; Pham T; Furth EE; Zhuang Z
J Natl Cancer Inst; 1997 Oct; 89(19):1448-53. PubMed ID: 9326914
[TBL] [Abstract][Full Text] [Related]
15. Folic acid supplementation inhibits recurrence of colorectal adenomas: a randomized chemoprevention trial.
Jaszewski R; Misra S; Tobi M; Ullah N; Naumoff JA; Kucuk O; Levi E; Axelrod BN; Patel BB; Majumdar AP
World J Gastroenterol; 2008 Jul; 14(28):4492-8. PubMed ID: 18680228
[TBL] [Abstract][Full Text] [Related]
16. Low expression of reduced folate carrier-1 and folylpolyglutamate synthase correlates with lack of a deleted in colorectal carcinoma mRNA splice variant in normal-appearing mucosa of colorectal carcinoma patients.
Wettergren Y; Odin E; Nilsson S; Willen R; Carlsson G; Gustavsson B
Cancer Detect Prev; 2005; 29(4):348-55. PubMed ID: 16122883
[TBL] [Abstract][Full Text] [Related]
17. Molecular biology of colorectal cancer.
Gryfe R; Swallow C; Bapat B; Redston M; Gallinger S; Couture J
Curr Probl Cancer; 1997; 21(5):233-300. PubMed ID: 9438104
[TBL] [Abstract][Full Text] [Related]
18. Effect of folic acid supplementation on genomic DNA methylation in patients with colorectal adenoma.
Pufulete M; Al-Ghnaniem R; Khushal A; Appleby P; Harris N; Gout S; Emery PW; Sanders TA
Gut; 2005 May; 54(5):648-53. PubMed ID: 15831910
[TBL] [Abstract][Full Text] [Related]
19. Use of crypt isolation to determine loss of heterozygosity of multiple tumor suppressor genes in colorectal carcinoma.
Sugai T; Habano W; Nakamura S; Yoshida T; Uesugi N; Sasou S; Itoh C; Katoh R
Pathol Res Pract; 2000; 196(3):145-50. PubMed ID: 10729918
[TBL] [Abstract][Full Text] [Related]
20. Expression of DCC protein in colorectal tumors and its relationship to tumor progression and metastasis.
Saito M; Yamaguchi A; Goi T; Tsuchiyama T; Nakagawara G; Urano T; Shiku H; Furukawa K
Oncology; 1999; 56(2):134-41. PubMed ID: 9949300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
